Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer

BACKGROUND: Activating mutations of the epidermal growth factor receptor (EGFR) confer sensitivity to the tyrosine kinase inhibitors (TKi), gefitinib and erlotinib. We analysed EGFR expression, EGFR mutation status and gene expression profiles of prostate cancer (PC) to supply a rationale for EGFR t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Peraldo-Neia, Caterina, Migliardi, Giorgia, Mello-Grand, Maurizia, Montemurro, Filippo, Segir, Raffaella, Pignochino, Ymera, Cavalloni, Giuliana, Torchio, Bruno, Mosso, Luciano, Chiorino, Giovanna, Aglietta, Massimo
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2011
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3040720/
https://ncbi.nlm.nih.gov/pubmed/21266046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-31
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items